@Royalsandman
didn't catch your post earlier, but hope you are OK there and for what its worth I think a lot of us here have probably gone through a similar experience and/or lost a lot of money on the share market.
but in this case.. it's not over yet, not many biotechs on the ASX (none that I know of) could have two or three products in the US market next year... Ryoncil BLA re-submission is still on the cards, as well the our CHF product which is going for accelerated approval. And that COVID ARDs trial Novartis didn't want to run... well the EUA is still there is Mesoblast can run it (I think it'll be funded by the NIH, like the first trial) and generate the results it did for the first trial for under 60's with a high CRP... that's yet another product that could be in the market.
we all get knocked down, and it's how we get back up that defines us.
Ann: Update on Novartis Agreement, page-658
-
- There are more pages in this discussion • 193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $5.605M | 3.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 55197 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 29782 | 3 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |